Benefits of treatment with favipiravir in hospitalized patients for COVID-19: a retrospective observational case–control study

BACKGROUND: Although more than a year past since COVID-19 was defined, there is no specific treatment yet. Since COVID-19 management differs over time, it is hard to determine which therapy is more efficacious. In this study, we aimed to evaluate the efficacy of the regimen with Favipiravir (FPV) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ucan, Anıl, Cerci, Pamir, Efe, Serdar, Akgun, Hakan, Ozmen, Ahmet, Yagmuroglu, Aysel, Bilgin, Muzaffer, Avci, Deniz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148395/
https://www.ncbi.nlm.nih.gov/pubmed/34034765
http://dx.doi.org/10.1186/s12985-021-01577-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148395/
https://www.ncbi.nlm.nih.gov/pubmed/34034765
http://dx.doi.org/10.1186/s12985-021-01577-1

Ejemplares similares